Exploring neutron capture therapy with 33S and 10B

被引:2
|
作者
Lopez-Casas, I. [1 ]
Praena, J. [1 ]
Arias de Saavedra, F. [1 ]
Sabate-Gilarte, M. [2 ,3 ]
Porras, I. [1 ]
机构
[1] Univ Granada, Granada, Spain
[2] Univ Seville, Seville, Spain
[3] European Org Nucl Res CERN, Geneva, Switzerland
关键词
Neutron capture therapy; Epithermal neutrons; S-33 as Neutron target; Dose rate on tissue;
D O I
10.1016/j.apradiso.2020.109220
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The S-33(n,alpha)Si-30 reaction was proposed as cooperative neutron capturer to B-10(n,alpha)Li-7 in Neutron Capture Therapy (NCT). At that moment, the available S-33(n,alpha)Si-30 cross-section data were scarce and discrepant in key energy ranges for its use in NCT. Since then, three experiments have been carried out at n_TOF facility at CERN and at Institut Laue-Langevin. These new data are used for the calculation of the dose rate on ICRU-4 tissue by using kerma factors, a simplified model of tissue and a 13.45 keV neutron beam, energy of the most important S-33 (n,alpha)Si-30 resonance. A significant enhancement of the dose rate due to the presence of S-33 is shown. In spite of the limitations, the cooperative action of S-33 and B-10 is an interesting possibility to be studied for accelerator-based neutron sources with non-moderated neutrons.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Pharamacokinetic Modeling for Boronophenylalanine-fructose Mediated Neutron Capture Therapy: 10B Concentration Predictions and Dosimetric Consequences
    W.S. Kiger
    M.R. Palmer
    K.J. Riley
    R.G. Zamenhof
    P.M. Busse
    Journal of Neuro-Oncology, 2003, 62 (1) : 171 - 186
  • [22] Pharamacokinetic modeling for boronophenylalanine-fructose mediated neutron capture therapy:: 10B concentration predictions and dosimetric consequences
    Kiger, WS
    Palmer, MR
    Riley, KJ
    Zamenhof, RG
    Busse, PM
    JOURNAL OF NEURO-ONCOLOGY, 2003, 62 (01) : 171 - 186
  • [23] Synthesis of 8-[10B]-dihydroxyboryl-harmine, a potential agent for boron neutron capture therapy.
    Sintas, JA
    Macareno, NJ
    Vitale, AA
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2000, 43 (01): : 97 - 101
  • [24] Pharamacokinetic modeling for boronophenylalanine-fructose mediated neutron capture therapy:10B concentration predictions and dosimetric consequences
    W. S. Kiger
    M. R. Palmer
    K. J. Riley
    R. G. Zamenhof
    P. M. Busse
    Journal of Neuro-Oncology, 2003, 62 : 171 - 186
  • [25] INFLUENCE OF NEUTRON SOURCES AND 10B CONCENTRATION ON BORON NEUTRON CAPTURE THERAPY FOR SHALLOW AND DEEPER NON-SMALL CELL LUNG CANCER
    Yu, Haiyan
    Tang, Xiaobin
    Shu, Diyun
    Liu, Yuanhao
    Geng, Changran
    Gong, Chunhui
    Hang, Shuang
    Chen, Da
    HEALTH PHYSICS, 2017, 112 (03): : 258 - 265
  • [26] Neutron transmutation of 10B doped diamond
    Jagannadham, K.
    Reed, M. L.
    Lance, M. J.
    Watkins, T. R.
    Verghese, K.
    Butler, J. E.
    Smirnov, A.
    DIAMOND AND RELATED MATERIALS, 2007, 16 (01) : 50 - 62
  • [27] Measurements of the 33S(n, α)30Si cross-section at n_TOF and ILL: Implications in neutron capture therapy
    Praena, Javier
    Lopez-Casas, Isabel
    Sabate-Gilarte, Marta
    Arias de Saavedra, Fernando
    Porras, Ignacio
    ND 2019: INTERNATIONAL CONFERENCE ON NUCLEAR DATA FOR SCIENCE AND TECHNOLOGY, 2020, 239
  • [28] Proton and neutron pair correlations in 10B
    Morita, H.
    Kanada-En'Yo, Y.
    11TH INTERNATIONAL CONFERENCE ON CLUSTERING ASPECTS OF NUCLEAR STRUCTURE AND DYNAMICS, 2017, 863
  • [29] Total neutron cross section of 10B
    Brusegan, A
    Crametz, A
    Macavero, E
    Plompen, AJM
    Schubert, W
    Van der Vorst, C
    Wattecamps, E
    INTERNATIONAL CONFERENCE ON NUCLEAR DATA FOR SCIENCE AND TECHNOLOGY, VOL 59, PT 1 AND 2, 1997, 59 : 1283 - 1285
  • [30] Microanalysis of PPM-order 10B concentrations in tissue for neutron capture therapy by prompt gamma-ray spectrometry
    Kobayashi, T.
    Kanda, K.
    Proceedings of the International Congress of Radiation Research, 1984, : 4 - 15